CCT8 has an alternative name of renal carcinoma antigen NY-REN-15, and 65 distinct antigens (NY-REN-1 to NY-REN-65) reactive with autologous IgG were found through SEREX analysis of four renal cancer patients and were characterized according to cDNA sequence, mRNA expression pattern, and reactivity with allogeneic sera[13]. This evidence concerns the gene CCT8 and carcinoma.